| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |